Cargando…
Prognostic and Immune-Infiltrate Significance of miR-222-3p and Its Target Genes in Thyroid Cancer
Thyroid cancer (THCA) is a common endocrine malignancy. With increasing incidence and low mortality, balancing the therapeutic approach is an inevitable issue. This study aimed to confirm the role of miR-222-3p and its target genes in THCA survival and immune infiltration. From different expression...
Autores principales: | Zhang, Taofeng, Chen, Yihuan, Lin, Weixun, Zheng, Jiehua, Liu, Yiyuan, Zou, Juan, Cai, Jiehui, Chen, Yaokun, Li, Zhiyang, Chen, Yexi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8562566/ https://www.ncbi.nlm.nih.gov/pubmed/34737762 http://dx.doi.org/10.3389/fgene.2021.710412 |
Ejemplares similares
-
The Global, Regional, and National Burden and Trends of Breast Cancer From 1990 to 2019: Results From the Global Burden of Disease Study 2019
por: Xu, Shangbo, et al.
Publicado: (2021) -
Identification of immune-related lncRNAs to improve the prognosis prediction for patients with papillary thyroid cancer
por: Li, Zhiyang, et al.
Publicado: (2021) -
Development and validation of a novel endoplasmic reticulum stress-related lncRNA prognostic signature and candidate drugs in breast cancer
por: Cai, Jiehui, et al.
Publicado: (2022) -
Addition of Capecitabine to Adjuvant Chemotherapy May be the Most Effective Strategy for Patients With Early-Stage Triple-Negative Breast Cancer: A Network Meta-Analysis of 9 Randomized Controlled Trials
por: Li, Zhiyang, et al.
Publicado: (2022) -
Comparative efficacy and safety of different combinations of three CDK4/6 inhibitors with endocrine therapies in HR+/HER-2 − metastatic or advanced breast cancer patients: a network meta-analysis
por: Liu, Yiyuan, et al.
Publicado: (2023)